Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M JPY Estimates in M JPY
Fiscal Period March 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 1 311 665 1 300 316 1 306 348 1 274 827 1 277 682 1 342 347
EBITDA 324 621 278 121 307 370 316 993 322 434 358 048
Operating profit (EBIT) 260 830 213 258 243 912 257 148 264 116 289 774
Pre-Tax Profit (EBT) 281 769 218 113 248 967 262 926 267 912 295 675
Net income 218 701 164 679 222 265 203 519 208 239 226 903
P/E ratio 14,1x 19,9x 14,4x 14,1x 14,1x 12,6x
EPS ( JPY ) 104 81,1 115 113 113 126
Dividend per Share ( JPY ) 34,0 36,0 38,0 40,9 43,4 47,4
Yield 2,32% 2,23% 2,29% 2,57% 2,73% 2,98%
Reference price ( JPY ) 1 466,000 1 614,000 1 658,500 1 590,000 1 590,000 1 590,000
Announcement Date 04/27/2017
12:00am
04/26/2018
12:00am
04/25/2019
12:00am
- - -
Finances - Leverage
Actuals in M JPY Estimates in M JPY
Fiscal Period March 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt - - - - - -
Finance 354 477 345 248 311 074 457 899 578 604 671 618
Operating income (EBITDA) 324 621 278 121 307 370 316 993 322 434 358 048
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 29 010 25 077 25 190 39 038 38 698 33 698
Free Cash Flow (FCF) 162 229 190 815 233 440 36 324 214 558 226 182
Book Value Per Share (BVPS) ( JPY ) 616 642 667 753 809 880
Cash Flow per Share ( JPY ) 134 113 148 141 151 158
Announcement Date 04/27/2017
12:00am
04/26/2018
12:00am
04/25/2019
12:00am
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 2 954 864 M JPY -
Entreprise Value (EV) 2 496 965 M JPY 2 376 260 M JPY
Valuation 2020e 2021e
P/E ratio (Price / EPS) 14,1x 14,1x
Capitalization / Revenue 2,32x 2,31x
EV / Revenue 1,96x 1,95x
EV / EBITDA 7,88x 7,74x
Yield (DPS / Price) 2,57% 2,73%
Price to book (Price / BVPS) 2,11x 1,97x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 20,2% 20,7%
Operating Leverage (Delta EBIT / Delta Sales) - 12,1x
Net Margin (Net Profit / Revenue) 16,0% 16,3%
ROA (Net Profit / Asset) 11,6% 10,7%
ROE (Net Profit / Equities) 15,8% 15,5%
Rate of Dividend 36,2% 38,5%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   3,06% 3,03%
Cash Flow / Sales 20,6% 21,9%
Capital Intensity (Assets / Sales) 1,38x 1,53x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend